Merck files in US for emergency FDA authorization for Covid treatment pill after trial data showed it cut hospitalizations in half

Merck and its partner Ridgeback Biotherapeutics announced on Monday that they’ve submitted an emergency authorization application to the US Food and Drug Administration (FDA) for their oral antiviral Covid treatment molnupiravir.

The US-based pharmaceutical company revealed the request had been made to the FDA, with the hope that it will become the first authorized oral antiviral Covid treatment following positive results from Merck’s Phase 3 clinical trial.“The extraordinary impact of this pandemic demands that we move with unprecedented urgency, and that is what our teams have done by submitting this application for molnupiravir to the FDA within 10 days of receiving the data,” Merck’s chief executive officer and president, Robert M. Davis, stated in a press release on the company’s website. Merck described the development as a “critical step” towards making the treatment available to individuals at home, reducing the risk of severe illness and cutting in half the hospitalization rates among individuals infected with the virus.In the hope that the drug will be given the green light by the FDA, Merck has already begun producing the treatment, expecting to have 10 million courses of molnupiravir ready for distribution by the end of 2021, with more due in 2022. 

Also on
More demand, more products: Pfizer testing ‘oral drug’ to prevent Covid-19 in people exposed to virus

Anticipating Merck’s successful trials, the US government ordered 1.7 million courses of molnupiravir, as part of a procurement agreement earlier this year, with other supply and advance-purchase deals similarly signed off with countries around the world.To help boost the production of the treatment, allowing it to be more quickly distributed in low and middle income countries, Merck has agreed a non-exclusive voluntary licensing agreement with Indian manufacturers, hoping to secure authorization to ensure widespread access to the medicine.If you like this story, share it with a friend!

Source link

Sign Up for Our Newsletters

Keep up to date and get notified on new posts!

You May Also Like

Trump’s on-off ally Lindsey Graham says police should ‘whack’ protesters who ‘get out of line’ at rally for jailed Capitol Rioters

320Views Republican Sen. Lindsey Graham has urged police in Washington, DC to…

Ex-CIA chief’s call to prosecute sources who outed alleged plot to target Assange ‘CONFIRMS’ story, WikiLeaks editor-in-chief says

384Views WikiLeaks Editor-in-Chief Kristinn Hrafnsson said former CIA Director Mike Pompeo has…

Pentagon’s archbishop says troops can’t be forced to get Covid jab against their conscience as branches scrutinize exemptions

570Views The top Catholic official in the US military has declared that…

FDA panel gives nod to Johnson & Johnson booster Covid-19 jabs

750Views A day after recommending Moderna’s Covid-19 booster proposal, an advisory vaccine…